Journal of AIDS & Clinical Research

Rosario Gravier Hernández

Publications

• Research Article
  Protocol of Determining the Effect of Vimang^® and Spirel^® Supplementation in Aids Patients with Delayed Diagnosis of HIV: An Open Randomized Controlled Trial
  Author(s): Lizette Gil del Valle, Vianka Calás Hechavarria, Rosario Gravier Hernández, Daymé Hernández Requejo, Sirley González- Laime, Iliana Filgueira Gómez, Zuleika Casamayor Laime, Mariela Guevara-García and Jorge Pérez-AvilaLizette Gil del Valle, Vianka Calás Hechavarria, Rosario Gravier Hernández, Daymé Hernández Requejo, Sirley González- Laime, Iliana Filgueira Gómez, Zuleika Casamayor Laime, Mariela Guevara-García and Jorge Pérez-Avila
  
  Background: Infection by Human immunodeficiency virus (VIH) constitutes a world health problem. The antiretroviral therapy accordingly recent WHO recommendation is proposed for all HIV seropositive individuals. Treatment optimization is encouraged due to certain risk of toxic adverse effects and resistance. The use of antioxidants has been indicated as a plausible option in these patients indeed pre or post exposition to antiretroviral treatment. Methods: In an open randomized control trial, 170 aids delayed diagnosis patients whose received prescription of High active antiretroviral therapy (HAART) will selected to be covered under Hospital-IPK monitoring consults (Cuban Referral HIV/aids Research Centre). Patients will be randomised to receive 10 mL of Vimang® aqueous extract twice a day or Spirel® tablets (400 mg) three times a da.. Read More»
  DOI: 10.4172/2155-6113.1000569

  Abstract PDF